enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Newly Published Data Indicates St. Jude Medical Trifecta ...

    www.aol.com/news/2013-03-19-newly-published-data...

    The Trifecta (TM) Valve. (Photo: St. Jude Medical, Inc.) Conducted at 31 medical centers in the U.S., Canada and Europe, the study followed 1,014 eligible patients implanted with the Trifecta ...

  3. Medical device reporting - Wikipedia

    en.wikipedia.org/wiki/Medical_device_reporting

    Medical device reporting (MDR) is the procedure for the Food and Drug Administration to get significant medical device adverse events information from manufacturers, importers and user facilities, so these issues can be detected and corrected quickly, and the same lot of that product may be recalled.

  4. FDA Adverse Event Reporting System - Wikipedia

    en.wikipedia.org/wiki/FDA_Adverse_Event...

    The FDA uses FAERS to monitor for new adverse events and medication errors that might occur with these products. It is a system that measures occasional harms from medications to ascertain whether the risk–benefit ratio is high enough to justify continued use of any particular drug and to identify correctable and preventable problems in ...

  5. US FDA mandates label updates on CAR-T cancer therapies - AOL

    www.aol.com/news/us-fda-mandates-label-updates...

    US FDA mandates label updates on CAR-T cancer therapies. April 18, 2024 at 6:39 PM (Reuters) - The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology ...

  6. 'I hit the trifecta': She was battling cancer. Then came ...

    www.aol.com/news/2020-05-26-i-hit-the-trifecta...

    In the age of COVID-19, cancer hospitals like Memorial Sloan Kettering have been forced to reimagine how to care for patients like 27-year-old Eliza Paris. 'I hit the trifecta': She was battling ...

  7. Bi-specific T-cell engager - Wikipedia

    en.wikipedia.org/wiki/Bi-specific_T-cell_engager

    Bi-specific T-cell engager (BiTE) is a class of artificial bispecific monoclonal antibodies that are investigated for use as anti-cancer drugs. They direct a host's immune system, more specifically the T cells ' cytotoxic activity, against cancer cells.

  8. Elexacaftor/tezacaftor/ivacaftor - Wikipedia

    en.wikipedia.org/wiki/Elexacaftor/tezacaftor/...

    FDA approval for children aged 6–11 was added in January 2021, after a third clinical trial was completed. [33] In 2023, approval was extended to children 2–5. [34] The US Food and Drug Administration (FDA) granted the application priority review, in addition to fast track, breakthrough therapy, and orphan drug designations.

  9. Abbott's heart valve repair device gets FDA advisers' backing

    www.aol.com/news/abbotts-heart-valve-repair...

    FDA's advisory panel meet followed the agency's staff on Friday noting the lack of signs of reduced deaths or hospitalizations in patients who received the implant compared with those on medical ...